To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Procedural sedation with propofol vs. midazolam/ketamine for painful manipulation in ER

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
August 2013

Procedural sedation with propofol vs. midazolam/ketamine for painful manipulation in ER

Vol: 2| Issue: 7| Number:178| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Procedural Sedation with Propofol for Painful Orthopaedic Manipulation in the Emergency Department Expedites Patient Management Compared with a Midazolam/Ketamine Regimen

J Bone and Joint Surg Am; 2011; 93: 2255-2252

Contributing Authors:
Ofir Uri Eyal Behrbalk Amir Haim Ehud Kaufman Pinchas Halpern

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty adults with orthopaedic injuries requiring painful manipulation were randomized to receive either propofol or midazolam/ketamine. Results indicated that the average recovery time and total sedation time were significantly shorter in patients who received propofol in comparison to those who received midazolam/ketamine. Patients in the propofol group had higher rates of adverse events; however...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue